U.S. CDC Issued Health Alert Network Update Regarding Monkeypox Outbreak

The U.S. CDC Health Alert Network (HAN) issued an Offical Health Update (CDCHAN-00472) regarding the expanding monkeypox virus outbreak in the USA,

Published on July 30, 2022, this HAN update alerts clinicians to clinical considerations for preventing, diagnosing, and managing monkeypox in people with HIV, children, adolescents, and pregnant or breastfeeding women.

These newly released clinical considerations complement existing guidance for managing monkeypox and provide information on the signs and symptoms of Monkeypox virus (MPXV) infection, pre-and post-exposure prevention, treatment, and infection control in these populations.

The CDC says 'clinicians should be familiar with unique clinical considerations for monkeypox in these patient populations.'

'A broad diagnostic approach is encouraged to distinguish MPXV infection from other causes of fever and rash illness.'

'Testing should be performed on persons for whom monkeypox is suspected based on clinical presentation or epidemiologic criteria.'

Moreover, the CDC encourages vaccinations with the U.S. FDA-approved Jynneos vaccine for specific individuals.

In the USA, there have been 5,189 MPXV infections across 47 states, Washington, D.C., and Puerto Rico, since early May 2022. This data includes two children who have been diagnosed with MPXV.

Furthermore, New York and San Francisco announced emergency status on July 28, 2022. 

And globally, data sources indicate about 22,870 MPXV cases and (3) related fatalities have been reported as of July 31, 2022.

Monkeypox vaccines news is posted at PrecisionVaccinations.com/Monkeypox.

Note: This CDC HAN was curated for mobile readership. Interested readers should view the entire HAN.